Do analysts prefer BIAF or TGHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GrowHub 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, BIAF or TGHL?

GrowHub has lower revenue, but higher earnings than bioAffinity Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $6.16M 0.63 -$14.91M -$11.77 N/A GrowHub $60K 248.36 -$13.38M N/A N/A

Do analysts recommend TC or BIAF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Token Cat 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, TC or BIAF?

Token Cat has higher earnings, but lower revenue than bioAffinity Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Token Cat $850K 4.88 $320K N/A N/A bioAffinity Technologies $6.16M 0.63 -$14.91M -$11.77 N/A

Does the media favor TC or BIAF?

In the previous week, Token Cat had 15 more articles in the media than bioAffinity Technologies. MarketBeat recorded 17 mentions for Token Cat and 2 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 0.20 beat Token Cat's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Token Cat 0 Very Positive mention(s) 0 Positive mention(s) 17 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral bioAffinity Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BIAF or SWVL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Swvl 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, BIAF or SWVL?

Swvl has higher revenue and earnings than bioAffinity Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $6.16M 0.63 -$14.91M -$11.77 N/A Swvl $24.17M 0.57 $1.31M N/A N/A

Does the media refer more to BIAF or SWVL?

In the previous week, bioAffinity Technologies had 1 more articles in the media than Swvl. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for Swvl. Swvl's average media sentiment score of 0.59 beat bioAffinity Technologies' score of 0.20 indicating that Swvl is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment bioAffinity Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Swvl 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BIAF or BTOC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Armlogi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate BIAF or CISO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CISO Global 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

bioAffinity Technologies (BIAF) Competitors

$0.82 -0.01 (-1.45%)

As of 09:53 AM Eastern

Compare

BIAF vs. TGHL, TC, SWVL, BTOC, and CISO

Should you buy bioAffinity Technologies stock or one of its competitors? MarketBeat compares bioAffinity Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with bioAffinity Technologies include GrowHub (TGHL), Token Cat (TC), Swvl (SWVL), Armlogi (BTOC), and CISO Global (CISO). These companies are all part of the "business services" industry.

How does bioAffinity Technologies compare to GrowHub?

bioAffinity Technologies (NASDAQ:BIAF) and GrowHub (NASDAQ:TGHL) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

GrowHub has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -280.53%. GrowHub's return on equity of 0.00% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-280.53%	-285.75%	-143.71%
GrowHub	N/A	N/A	N/A

GrowHub has lower revenue, but higher earnings than bioAffinity Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	0.63	-$14.91M	-$11.77	N/A
GrowHub	$60K	248.36	-$13.38M	N/A	N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than GrowHub. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for GrowHub. bioAffinity Technologies' average media sentiment score of 0.20 beat GrowHub's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
bioAffinity Technologies	Neutral
GrowHub	Neutral

1.6% of bioAffinity Technologies shares are held by institutional investors. 2.7% of bioAffinity Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GrowHub	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

bioAffinity Technologies and GrowHub tied by winning 5 of the 10 factors compared between the two stocks.

How does bioAffinity Technologies compare to Token Cat?

Token Cat (NASDAQ:TC) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

In the previous week, Token Cat had 15 more articles in the media than bioAffinity Technologies. MarketBeat recorded 17 mentions for Token Cat and 2 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 0.20 beat Token Cat's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Token Cat	0 Very Positive mention(s)	0 Positive mention(s)	17 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

8.9% of Token Cat shares are held by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are held by institutional investors. 0.5% of Token Cat shares are held by company insiders. Comparatively, 2.7% of bioAffinity Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Token Cat has higher earnings, but lower revenue than bioAffinity Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Token Cat	$850K	4.88	$320K	N/A	N/A
bioAffinity Technologies	$6.16M	0.63	-$14.91M	-$11.77	N/A

Token Cat has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, bioAffinity Technologies has a beta of -1.11, suggesting that its stock price is 211% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Token Cat	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Token Cat has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -280.53%. Token Cat's return on equity of 0.00% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Token Cat	N/A	N/A	N/A
bioAffinity Technologies	-280.53%	-285.75%	-143.71%

Summary

Token Cat beats bioAffinity Technologies on 8 of the 11 factors compared between the two stocks.

How does bioAffinity Technologies compare to Swvl?

bioAffinity Technologies (NASDAQ:BIAF) and Swvl (NASDAQ:SWVL) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Swvl has higher revenue and earnings than bioAffinity Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	0.63	-$14.91M	-$11.77	N/A
Swvl	$24.17M	0.57	$1.31M	N/A	N/A

bioAffinity Technologies has a beta of -1.11, suggesting that its stock price is 211% less volatile than the broader market. Comparatively, Swvl has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Swvl	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Swvl has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -280.53%. Swvl's return on equity of 0.00% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-280.53%	-285.75%	-143.71%
Swvl	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than Swvl. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for Swvl. Swvl's average media sentiment score of 0.59 beat bioAffinity Technologies' score of 0.20 indicating that Swvl is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Swvl	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 34.0% of Swvl shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by insiders. Comparatively, 29.9% of Swvl shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Swvl beats bioAffinity Technologies on 9 of the 11 factors compared between the two stocks.

How does bioAffinity Technologies compare to Armlogi?

bioAffinity Technologies (NASDAQ:BIAF) and Armlogi (NASDAQ:BTOC) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

In the previous week, bioAffinity Technologies had 2 more articles in the media than Armlogi. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for Armlogi. bioAffinity Technologies' average media sentiment score of 0.20 beat Armlogi's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
bioAffinity Technologies	Neutral
Armlogi	Neutral

1.6% of bioAffinity Technologies shares are held by institutional investors. 2.7% of bioAffinity Technologies shares are held by insiders. Comparatively, 66.9% of Armlogi shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

bioAffinity Technologies has a beta of -1.11, suggesting that its share price is 211% less volatile than the broader market. Comparatively, Armlogi has a beta of 2.75, suggesting that its share price is 175% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Armlogi	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

bioAffinity Technologies has higher earnings, but lower revenue than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	0.63	-$14.91M	-$11.77	N/A
Armlogi	$190.41M	0.07	-$15.35M	-$0.47	N/A

Armlogi has a net margin of -10.70% compared to bioAffinity Technologies' net margin of -280.53%. Armlogi's return on equity of -104.33% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-280.53%	-285.75%	-143.71%
Armlogi	-10.70%	-104.33%	-13.30%

Summary

Armlogi beats bioAffinity Technologies on 7 of the 13 factors compared between the two stocks.

How does bioAffinity Technologies compare to CISO Global?

bioAffinity Technologies (NASDAQ:BIAF) and CISO Global (NASDAQ:CISO) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

bioAffinity Technologies has a beta of -1.11, meaning that its stock price is 211% less volatile than the broader market. Comparatively, CISO Global has a beta of 1.74, meaning that its stock price is 74% more volatile than the broader market.

1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 40.1% of CISO Global shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by insiders. Comparatively, 23.8% of CISO Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CISO Global has a net margin of -16.69% compared to bioAffinity Technologies' net margin of -280.53%. CISO Global's return on equity of -32.61% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-280.53%	-285.75%	-143.71%
CISO Global	-16.69%	-32.61%	-17.19%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CISO Global	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, bioAffinity Technologies had 2 more articles in the media than CISO Global. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for CISO Global. bioAffinity Technologies' average media sentiment score of 0.20 beat CISO Global's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
bioAffinity Technologies	Neutral
CISO Global	Neutral

CISO Global has higher revenue and earnings than bioAffinity Technologies. CISO Global is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	0.63	-$14.91M	-$11.77	N/A
CISO Global	$25.66M	0.47	-$8.07M	-$0.24	N/A

Summary

CISO Global beats bioAffinity Technologies on 9 of the 13 factors compared between the two stocks.

Get bioAffinity Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BIAF vs. The Competition

Export

Metric	bioAffinity Technologies	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.90M	$3.76B	$6.98B	$12.46B
Dividend Yield	N/A	2.16%	2.66%	6.52%
P/E Ratio	-0.07	21.80	27.78	24.70
Price / Sales	0.63	326.25	537.18	98.72
Price / Cash	N/A	64.18	29.65	49.23
Price / Book	0.50	8.67	11.09	6.49
Net Income	-$14.91M	$23.68M	$3.57B	$336.25M
7 Day Performance	1.79%	1.23%	1.15%	0.35%
1 Month Performance	-52.72%	13.43%	6.08%	3.91%
1 Year Performance	-90.12%	62.61%	33.32%	23.88%

bioAffinity Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BIAF bioAffinity Technologies	0.8711 of 5 stars	$0.82 -1.4%	N/A	-90.0%	$3.90M	$6.16M	N/A	10	Analyst Downgrade
TGHL GrowHub	N/A	$0.60 +8.7%	N/A	N/A	$13.89M	$60K	N/A	12	Gap Down
TC Token Cat	0.5315 of 5 stars	$1.85 -76.9%	N/A	-81.4%	$13.86M	$850K	N/A	620	Gap Down High Trading Volume
SWVL Swvl	0.9478 of 5 stars	$1.34 -3.2%	N/A	-66.5%	$13.71M	$24.17M	N/A	2	Gap Down
BTOC Armlogi	0.8615 of 5 stars	$0.30 +2.4%	N/A	-80.1%	$13.31M	$190.41M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BIAF) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

bioAffinity Technologies (BIAF) Competitors

BIAF vs. TGHL, TC, SWVL, BTOC, and CISO

How does bioAffinity Technologies compare to GrowHub?

Summary

How does bioAffinity Technologies compare to Token Cat?

Summary

How does bioAffinity Technologies compare to Swvl?

Summary

How does bioAffinity Technologies compare to Armlogi?

Summary

How does bioAffinity Technologies compare to CISO Global?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIAF vs. The Competition

bioAffinity Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

bioAffinity Technologies (BIAF) Competitors

BIAF vs. TGHL, TC, SWVL, BTOC, and CISO

How does bioAffinity Technologies compare to GrowHub?

Is BIAF or TGHL more profitable?

Which has stronger valuation and earnings, BIAF or TGHL?

Does the media refer more to BIAF or TGHL?

Do institutionals and insiders hold more shares of BIAF or TGHL?

Do analysts prefer BIAF or TGHL?

Summary

How does bioAffinity Technologies compare to Token Cat?

Does the media favor TC or BIAF?

Do institutionals & insiders believe in TC or BIAF?

Which has better valuation & earnings, TC or BIAF?

Which has more risk & volatility, TC or BIAF?

Do analysts recommend TC or BIAF?

Is TC or BIAF more profitable?

Summary

How does bioAffinity Technologies compare to Swvl?

Which has preferable valuation & earnings, BIAF or SWVL?

Which has more volatility and risk, BIAF or SWVL?

Do analysts recommend BIAF or SWVL?

Is BIAF or SWVL more profitable?

Does the media refer more to BIAF or SWVL?

Do institutionals & insiders hold more shares of BIAF or SWVL?

Summary

How does bioAffinity Technologies compare to Armlogi?

Does the media refer more to BIAF or BTOC?

Do insiders and institutionals hold more shares of BIAF or BTOC?

Which has more risk and volatility, BIAF or BTOC?

Do analysts recommend BIAF or BTOC?

Which has higher earnings & valuation, BIAF or BTOC?

Is BIAF or BTOC more profitable?

Summary

How does bioAffinity Technologies compare to CISO Global?

Which has more volatility and risk, BIAF or CISO?

Do insiders and institutionals hold more shares of BIAF or CISO?

Is BIAF or CISO more profitable?

Do analysts rate BIAF or CISO?

Does the media refer more to BIAF or CISO?

Which has preferable earnings & valuation, BIAF or CISO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIAF vs. The Competition

bioAffinity Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools